Evaluation of the accuracy, exclusivity, limit-of-detection and ease-of-use of the LumiraDx SARS-CoV-2 test - A rapid, antigen-detecting point-of-care tool for the diagnosis of SARS-CoV-2 [Research Data]
收藏heiDATA2021-07-16 更新2026-05-11 收录
下载链接：
https://heidata.uni-heidelberg.de/citation?persistentId=doi:10.11588/DATA/D0ACC0
下载链接
链接失效反馈官方服务：
资源简介：
This repository includes data from a prospective, multi-centre diagnostic accuracy study. The study was conducted at two sites in Germany, Heidelberg and Berlin. Following routine testing with reverse-transcriptase polymerase chain reaction (RT-PCR), a second study-exclusive swab was performed for Ag-RDT testing. Routine swabs were nasopharyngeal (NP) or combined NP/oropharyngeal (OP) whereas the study-exclusive swabs were NP. To evaluate performance, sensitivity and specificity were assessed overall and in predefined sub analyses accordingly to viral load, days of symptoms and symptoms. In addition, further data from the participants were collected during interviews
提供机构：
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Medical Directorate; Virology, Heidelberg University Hospital; Department of Public Health Rhein Neckar Region; Foundation for Innovative New Diagnostics; Division of Clinical Tropical Medicine, Department of Infectious Diseases, University of Heidelberg, Heidelberg, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Tropical Medicine and International Health; Division of Clinical Tropical Medicine, Heidelberg University Hospital, Heidelberg; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Virology
创建时间：
2020-11-02
